Article Details

Eli Lilly pins injectable migraine med Emgality against Biohaven's oral rival Nurtec ODT in head-to ...

Retrieved on: 2021-06-15 10:50:00

Tags for this article:

Click the tags to see associated articles and topics

Eli Lilly pins injectable migraine med Emgality against Biohaven's oral rival Nurtec ODT in head-to .... View article details on hiswai:

Excerpt

The Indianapolis-based drugmaker on Tuesday said it will study its monthly injectable monoclonal antibody Emgality against Biohaven's every-other-day ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up